Post #192

The Azvudine tablet, which China approved in July last year to treat certain HIV-1 virus infections, has been given a conditional green light to treat adult patients with "normal type" COVID, the National Medical Products Administration said in a statement. "Normal type" COVID is a term China uses to refer to coronavirus infections where there are signs of pneumonia, but the patients haven't reached a severe stage. China in February allowed the use of Pfizer's oral treatment Paxlovid in adults with mild-to-moderate COVID and high risk of progressing to a severe condition. 🙃🙃 [source: Reuters]